Levitee Labs Inc. announced the appointment of Dr. Fady Hannah-Shmouni, a leading expert in neuroendocrinology and genetics from the United States’ National Institutes of Health (NIH), as Chief Medical and Scientific Officer and President of Levitee Clinics and Pharmacies. In this role, Dr. Hannah-Shmouni will oversee Levitee Labs’ medical affairs, research activities, and corporate medical strategy. He will work with relevant parties to provide oversight of Levitee Labs’ clinical and scientific agenda and partnerships with a special focus on mental illness treatment, including substance use and pain disorders. Prior to joining Levitee Labs, Dr. Hannah-Shmouni was a clinician scientist in neuroendocrinology, hypertension, and biochemical genetics at NIH (Maryland, USA) since 2015. He served as Director of the Office of Education’s Graduate Medical Education (GME) with the National Institute of Child Health and Human Development; Chief of the Internal Medicine, Endocrinology, and Genetics Inpatient Ward.